HIND - NASDAQ

Vyome Holdings, Inc.

HIND·NASDAQ

$5.73

+14%

HealthcareBiotechnology

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$151.09M

EPS-345.7400

P/E Ratio-1.29

Earnings Date05/18/2026

hind

Other Current Assets

Last Annual Value

114.00K

3-Year CAGR

-22%

5-Year CAGR

-12%

10-Year CAGR

92%

Adjust for Inflation

Vyome Holdings, Inc. Competitors Analysis of Other Current Assets

HIND · NASDAQ

Company	Other Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
Vyome Holdings, Inc. NASDAQ:HIND	114.00K	-21.9%	-13.7%	80.0%
Armata Pharmaceuticals, Inc. AMEX:ARMP	1.51M	-12.7%	N/A	9.6%
Codexis, Inc. NASDAQ:CDXS	6.06M	1.8%	59.9%	17.2%
Nuvectis Pharma, Inc. NASDAQ:NVCT	75.00K	8.3%	-3.8%	N/A
Sangamo Therapeutics, Inc. NASDAQ:SGMO	4.37M	-22.1%	N/A	N/A
Tonix Pharmaceuticals Holding Corp. NASDAQ:TNXP	5.47M	31.1%	35.9%	N/A
C4 Therapeutics, Inc. NASDAQ:CCCC	7.17M	7.9%	N/A	N/A
Acumen Pharmaceuticals, Inc. NASDAQ:ABOS	4.76M	34.4%	11.0%	N/A
Anixa Biosciences, Inc. NASDAQ:ANIX	713.00K	-16.9%	N/A	N/A
Atossa Therapeutics, Inc. NASDAQ:ATOS	4.32M	64.1%	27.1%	54.7%
Greenwich LifeSciences, Inc. NASDAQ:GLSI	0.00	N/A	N/A	N/A

Vyome Holdings, Inc. Fair Value Envelope

HIND · NASDAQ

Our analysis suggests that HIND has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.73, this represents a potential HIDDEN relative to our calculated worth for Vyome Holdings, Inc..

HIDDEN

Intrinsic Value

Current Price: $5.73

Related Guides

Blog Categories

Continue your HIND research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.